Active Ingredient History

  • Now
Sodelglitazar, formerly known as GW 677954, is a thiazole PPARδ receptor agonist developed by GlaxoSmithKline. While it is primarily active at the PPARδ receptor, it is considered a pan agonist with activity at PPARα and PPARγ receptors.   Wikipedia

  • SMILES: Cc1cc(SCc2sc(nc2C)c3ccc(cc3F)C(F)(F)F)ccc1OC(C)(C)C(=O)O
  • Mol. Mass: 499.55
  • ALogP: 7.12
  • ChEMBL Molecule:
More Chemistry
gw677954 | sodelglitazar


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue